Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019

Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019

Abstract Atrial fibrillation is a common clinical manifestation in hospitalized patients with coronavirus disease 2019 (COVID‐19). Medications used to treat atrial fibrillation, such as antiarrhythmic drugs and anticoagulants, may have significant drug interactions with emerging COVID‐19 treatments....

Full description

Bibliographic Details
Main Authors: Pattara Rattanawong, Win Shen, Hicham El Masry, Dan Sorajja, Komandoor Srivathsan, Arturo Valverde, Luis R. Scott
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
antiarrhythmic drug
atrial fibrillation
COVID‐19
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.017529

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.017529

Similar Items